Insider Trading & Ownership of Clarus Defined Exit I, L.P.

Location: Cambridge, MA
Summary: The estimated value of insider holdings of Clarus Defined Exit I, L.P. is at least $2,719,148 dollars as of 13 May 2021. Clarus Defined Exit I, L.P. is the 10%+ Owner of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $2.72M.
Signature: CLARUS DEFINED EXIT I, L.P., By: Clarus Ventures DE GP, L.P., its GP, By: Blackstone Clarus DE L.L.C., its GP, By: Blackstone Holdings II L.P., its sole member, By: Blackstone Holdings I/II GP L.L.C., its GP, By: /s/ Tabea Hsi, Senior Managing Director
All Insider Reports: All Insider Reports

Notify me when Clarus Defined Exit I, L.P. files a new Insider Trading report.

Ownership of Clarus Defined Exit I, L.P.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TRML	Tourmaline Bio, Inc.	10%+ Owner	$2,719,148			11 May 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.